European Journal of Clinical Oncology has announced almost 50 percent discount on article processing charge to commemorate its Anniversary. On behalf of the European journal of clinical oncology, as Editor-in-Chief, it is my distinct honour and privilege to inform you that, we have started the Journal, now we are celebrating the  Anniversary and we are privileged to welcome Analytical Society to our journal.

Scope of the journal:

 It mainly encompasses topics Cancer Biology, prostate cancer, colorectal cancer, cancer Immuno therapy, chemotherapy, cancer radiology, therapeutic cancer, cancer pathology reaching out to analytical scientists worldwide.

Journal accepts original manuscripts in the form of research articles, review articles, Clinical reviews, and commentaries, case reports, perspectives and short communications encompassing all aspects Clinical Oncology related topics for publication in open access platform. All the manuscript published are available freely online immediately after publication without any subscription charges or registration. Those who are interested to submit the editorials or their commentaries can submit at https://www.scholarscentral.org/submissions/european-clinical-oncology.html or you can mail  through this mail id as  an attachments  clinoncol@peerjournal.org/oncology@peerjournal.org .

Types of Cancer in Children:

In the United States in 2019, an estimated 11,060 new cases of cancer will be diagnosed among children from birth to 14 years, and about 1,190 children are expected to die from the disease. Although cancer death rates for this age group have declined by 65 percent from 1970 to 2016, cancer remains the leading cause of death from disease among children. The most common types of cancer diagnosed in children ages 0 to 14 years are leukemias, brain and other central nervous system (CNS) tumors, and lymphomas.

Treating Childhood Cancer:

Children's cancers are not always treated like adult cancers. Pediatric oncology is a medical specialty focused on the care of children with cancer. It's important to know that this expertise exists and that there are effective treatments for many childhood cancers.

How we work: After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days. A 21-day window time frame is allotted for peer-review process wherein multiple experts are contacted. Author proof is generated within 7 working days after the acceptance decision

Benefits on Publication: Open Access: Permanent free access to your article upon publication ensures extensive global reach and readership. Easy Article Sharing: Our open access enables you to share your article directly with colleagues through email and on social media via a single link, permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.

Global Marketing: Through promotion in a targeted global email announcement or press release, your article will be seen by thousands of the top-most thought-leaders in your field.

Regards

Alfreda Johnson

Managing Editor

European Journal of Clinical Oncology.

WhatsApp: +1504-608-2390

E-mail id: oncology@peerjournal.org